Theresa Heggie Biocryst Pharmaceuticals Inc (BCRX) insider trading activity

BCRX Quotes by TradingView

Theresa Heggie is Director of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 65,352 shares of BCRX, which is worth approximately $545,689. The most recent transaction as insider was on Aug 13, 2025, when has been sold 70,000 shares (Common Stock) at a price of $8.51 per share, resulting in proceeds of $595,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 65.4K
23.65% 3M change
23.65% 12M change
Total Value Held $545,689

THERESA HEGGIE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 13 2025
SELL
Open market or private sale
$595,700 $8.51 p/Share
70,000 Reduced 51.72%
65,352 Common Stock
Aug 13 2025
BUY
Exercise of conversion of derivative security
$291,200 $4.16 p/Share
70,000 Added 34.09%
135,352 Common Stock
Jun 12 2025
BUY
Grant, award, or other acquisition
-
12,500 Added 16.06%
65,352 Common Stock
Jun 14 2024
SELL
Open market or private sale
$40,924 $6.11 p/Share
6,698 Reduced 11.25%
52,852 Common Stock
Jun 12 2024
BUY
Grant, award, or other acquisition
-
6,820 Added 10.28%
59,550 Common Stock
May 31 2024
BUY
Grant, award, or other acquisition
$5,620 $6.46 p/Share
870 Added 1.62%
52,730 Common Stock
Feb 29 2024
BUY
Grant, award, or other acquisition
$5,624 $5.63 p/Share
999 Added 1.89%
51,860 Common Stock
Nov 30 2023
BUY
Grant, award, or other acquisition
$5,621 $5.88 p/Share
956 Added 1.84%
50,861 Common Stock
Aug 31 2023
BUY
Grant, award, or other acquisition
$5,624 $7.11 p/Share
791 Added 1.56%
49,905 Common Stock
Jun 13 2023
BUY
Grant, award, or other acquisition
-
16,745 Added 25.43%
49,114 Common Stock
May 31 2023
BUY
Grant, award, or other acquisition
$5,623 $8.27 p/Share
680 Added 2.06%
32,369 Common Stock
Feb 28 2023
BUY
Grant, award, or other acquisition
$5,619 $8.85 p/Share
635 Added 1.96%
31,689 Common Stock
Nov 30 2022
BUY
Grant, award, or other acquisition
$5,624 $13.36 p/Share
421 Added 1.34%
31,054 Common Stock
Aug 31 2022
BUY
Grant, award, or other acquisition
$5,616 $13.9 p/Share
404 Added 1.3%
30,633 Common Stock
Jun 07 2022
BUY
Grant, award, or other acquisition
-
12,866 Added 29.85%
30,229 Common Stock
May 31 2022
BUY
Grant, award, or other acquisition
$10,595 $9.31 p/Share
1,138 Added 6.15%
17,363 Common Stock
Feb 28 2022
BUY
Grant, award, or other acquisition
$9,999 $16.61 p/Share
602 Added 3.58%
16,225 Common Stock
Nov 30 2021
BUY
Grant, award, or other acquisition
$9,998 $12.06 p/Share
829 Added 5.04%
15,623 Common Stock
Aug 31 2021
BUY
Grant, award, or other acquisition
$9,998 $15.92 p/Share
628 Added 4.07%
14,794 Common Stock
May 28 2021
BUY
Grant, award, or other acquisition
$4,999 $15.77 p/Share
317 Added 2.19%
14,166 Common Stock
Feb 26 2021
BUY
Grant, award, or other acquisition
$4,991 $10.78 p/Share
463 Added 3.24%
13,849 Common Stock
Nov 30 2020
BUY
Grant, award, or other acquisition
$4,998 $5.11 p/Share
978 Added 6.81%
13,386 Common Stock
TH

Theresa Heggie

Director
Durham, NC

Track Institutional and Insider Activities on BCRX

Follow BIOCRYST PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCRX